Clinical trials
Shock, Cardiogenic trials in China with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2016 | 1 |
| 2018 | 1 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 3 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 6 |
| Not yet recruiting | 3 |
| Recruiting | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Beijing Anzhen Hospital | 2 |
| Renmin Hospital of Wuhan University | 2 |
| Shenzhen Core Medical Technology CO.,LTD. | 2 |
| China National Center for Cardiovascular Diseases | 1 |
| ForQaly Medical (Shanghai) Co., Ltd | 1 |
| Fujian Medical University | 1 |
| Nanjing Medical University | 1 |
| Qilu Hospital of Shandong University | 1 |
| Second Affiliated Hospital of Guangzhou Medical University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Shock, Cardiogenic | 12 |
| Coronary Disease | 1 |
| Heart Septal Defects, Ventricular | 1 |
| Myocardial Infarction | 1 |
| Shock | 1 |
| Shock, Septic | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.